Live feed
Filing
SC 13G
SC 13G0001193125-17-371797·CytomX Therapeutics, Inc.
Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Security class unavailable · CUSIP: 23284F105
Event date: 2017-12-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-371797
- Form type
- SC 13G
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Dec 18, 2017
- Reporting period
- Dec 08, 2017
- Description
- Schedule 13G beneficial ownership